KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Revenue (2016 - 2025)

Historic Revenue for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $94.9 million.

  • Dynavax Technologies' Revenue rose 1766.84% to $94.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.5 million, marking a year-over-year increase of 2672.55%. This contributed to the annual value of $277.2 million for FY2024, which is 1935.65% up from last year.
  • Per Dynavax Technologies' latest filing, its Revenue stood at $94.9 million for Q3 2025, which was up 1766.84% from $95.4 million recorded in Q2 2025.
  • Dynavax Technologies' Revenue's 5-year high stood at $256.5 million during Q2 2022, with a 5-year trough of $46.9 million in Q1 2023.
  • For the 5-year period, Dynavax Technologies' Revenue averaged around $101.6 million, with its median value being $80.6 million (2024).
  • Its Revenue has fluctuated over the past 5 years, first surged by 187777.36% in 2021, then plummeted by 7650.78% in 2023.
  • Quarter analysis of 5 years shows Dynavax Technologies' Revenue stood at $195.1 million in 2021, then dropped by 5.42% to $184.5 million in 2022, then tumbled by 69.87% to $55.6 million in 2023, then rose by 29.56% to $72.0 million in 2024, then skyrocketed by 31.71% to $94.9 million in 2025.
  • Its Revenue was $94.9 million in Q3 2025, compared to $95.4 million in Q2 2025 and $68.2 million in Q1 2025.